Latin America to use oral vaccine against COVID-19.

in HiveVenezuela2 months ago


Greetings to all my dear and esteemed followers of this valuable community, continuing with my publications today I will share with all of you a news that will undoubtedly change the course of the battle against COVID-19, and that is that an oral vaccine against this deadly disease has been released and will be used in Latin America.

It is no secret that at the present time every country in the world, together with the World Health Organization (WHO) and other non-governmental organizations, is waging a relentless battle against the deadly COVID-19 virus, this terrible disease continues to claim the lives of millions of people in the world and although many countries have been returning to normal in their daily activities, this deadly virus continues its expansion in every corner of the world.

In this great fight in which we are immersed each and every one of the citizens who live on this planet, complying with the established biosecurity norms and not constantly going out to the street, now is added the Oral vaccine that has already been developed and named Oravax, this vaccine was developed in Mexican laboratories and is composed of three proteins that are very similar to the COVID-19 virus. The initiation of vaccination with this pill will be of great help because it reduces the production costs of injected vaccines.


The development of this new oral vaccine will undoubtedly reduce considerably the production costs and also the cost of transporting the vaccine, since most of the injected vaccines that were developed at the beginning of the pandemic require minimum cold conditions to be able to be transported, which increased their production value. The high cost of air travel is a major constraint for these vaccines to reach third world countries. Oravax will undoubtedly reduce these transportation costs and will be able to be supplied to a greater number of people in the world.

This important medicine was developed by the Genomma laboratory, which is located in Mexico, but has branches in the United States. This important laboratory is also a specialist in developing solutions in the elaboration of oral medicines that are usually applied through injections. One of the most outstanding things about this news is that this vaccine will begin to be applied in Latin America and thus it will be possible to fight this deadly virus in a more effective way as far as vaccine application is concerned.

Reference Consulted

Article prepared by: